Dyslipidemia is a hallmark of nonalcoholic fatty liver disease (NAFLD) and the rs599839 variant in the CELSR2-PSRC1-SORT1 genetic cluster, has been associated with a protection against cardiovascular events. This evidence concerns the gene CELSR2 and metabolic dysfunction-associated steatotic liver disease.